DK0453042T3 - Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner - Google Patents
Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-onerInfo
- Publication number
- DK0453042T3 DK0453042T3 DK91200897T DK91200897T DK0453042T3 DK 0453042 T3 DK0453042 T3 DK 0453042T3 DK 91200897 T DK91200897 T DK 91200897T DK 91200897 T DK91200897 T DK 91200897T DK 0453042 T3 DK0453042 T3 DK 0453042T3
- Authority
- DK
- Denmark
- Prior art keywords
- 4alkyl
- compounds
- methyl
- hydroxyc1
- furanyl
- Prior art date
Links
- MPOYBFYHRQBZPM-UHFFFAOYSA-N 3h-pyridin-4-one Chemical class O=C1CC=NC=C1 MPOYBFYHRQBZPM-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- -1 5-methyl-2-furanyl Chemical group 0.000 abstract 2
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909008850A GB9008850D0 (en) | 1990-04-19 | 1990-04-19 | Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0453042T3 true DK0453042T3 (da) | 2000-04-25 |
Family
ID=10674694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91200897T DK0453042T3 (da) | 1990-04-19 | 1991-04-16 | Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5482943A (da) |
| EP (1) | EP0453042B1 (da) |
| JP (1) | JP3216889B2 (da) |
| KR (1) | KR100190297B1 (da) |
| CN (1) | CN1027506C (da) |
| AT (1) | ATE186301T1 (da) |
| AU (1) | AU636969B2 (da) |
| BG (1) | BG60394B1 (da) |
| CA (1) | CA2040086C (da) |
| CZ (1) | CZ281135B6 (da) |
| DE (1) | DE69131759T2 (da) |
| DK (1) | DK0453042T3 (da) |
| ES (1) | ES2140381T3 (da) |
| FI (1) | FI96206C (da) |
| GB (1) | GB9008850D0 (da) |
| GR (1) | GR3032122T3 (da) |
| HU (1) | HUT57763A (da) |
| IE (1) | IE911301A1 (da) |
| IL (1) | IL97892A (da) |
| NO (1) | NO176840C (da) |
| NZ (1) | NZ237713A (da) |
| PL (2) | PL169744B1 (da) |
| PT (1) | PT97395B (da) |
| RU (1) | RU2037495C1 (da) |
| SK (1) | SK279005B6 (da) |
| ZA (1) | ZA912913B (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2050069B1 (es) * | 1992-07-10 | 1994-12-16 | Vita Invest Sa | Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona. |
| JPH07508741A (ja) | 1992-07-13 | 1995-09-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 新規４−（３−ベンゾフラニル）ピペリジニル及び４−（３−ベンゾチエニル）ピペリジニル誘導体，ならびにそれらを含む製薬学的組成物 |
| SI0730594T1 (en) * | 1993-11-23 | 1999-12-31 | Janssen Pharmaceutica N.V. | 9-HYDROXY-PYRIDO (1,2-a)PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
| ES2141671B1 (es) * | 1997-12-26 | 2001-01-01 | Vita Invest Sa | Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| HU227118B1 (en) * | 2001-11-13 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one |
| ES2197801B1 (es) * | 2002-03-05 | 2005-03-16 | Ferrer Internacional,S.A | Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona. |
| WO2004009591A1 (en) * | 2002-07-22 | 2004-01-29 | Aurobindo Pharma Ltd. | A process for the preparation of antipsychotic risperidone |
| AU2003256006A1 (en) * | 2002-08-30 | 2004-03-19 | Sunil Sadanand Nadkarni | Improved process for preparation of risperidone |
| KR20040025224A (ko) * | 2002-09-18 | 2004-03-24 | 주식회사 대웅 | 2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-3-일)아세트알데히드 및 그 제조방법 |
| EP1560814A1 (en) | 2002-11-13 | 2005-08-10 | Synthon B.V. | Process for making risperidone and intermediates therefor |
| EP1615923A1 (en) * | 2003-04-22 | 2006-01-18 | Synthon B.V. | Risperidone monohydrochloride |
| HUP0401379A3 (en) * | 2004-07-08 | 2006-04-28 | Richter Gedeon Vegyeszet | Process for the preparation of risperidon |
| HUP0402163A2 (en) * | 2004-10-25 | 2006-05-29 | Richter Gedeon Vegyeszet | Process for the preparation of risperidone |
| EP1690540A1 (en) | 2005-02-15 | 2006-08-16 | Neuro3D | Composition comprising ocaperidone |
| EP1695973A1 (en) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidone salt and pharmaceutical compositions containing the same |
| JO2769B1 (en) * | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
| WO2009077551A1 (en) * | 2007-12-18 | 2009-06-25 | Janssen Pharmaceutica Nv | Process for preparing risperidone |
| WO2023135528A1 (en) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Heteroalicyclic derivatives and their use in the treatment of cns disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
| US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| CA2000786C (en) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
| GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
-
1990
- 1990-04-19 GB GB909008850A patent/GB9008850D0/en active Pending
-
1991
- 1991-03-28 US US07/676,681 patent/US5482943A/en not_active Expired - Lifetime
- 1991-04-05 NZ NZ237713A patent/NZ237713A/en unknown
- 1991-04-09 CA CA002040086A patent/CA2040086C/en not_active Expired - Lifetime
- 1991-04-11 AU AU74366/91A patent/AU636969B2/en not_active Expired
- 1991-04-16 DE DE69131759T patent/DE69131759T2/de not_active Expired - Lifetime
- 1991-04-16 JP JP10968691A patent/JP3216889B2/ja not_active Expired - Lifetime
- 1991-04-16 EP EP91200897A patent/EP0453042B1/en not_active Expired - Lifetime
- 1991-04-16 ES ES91200897T patent/ES2140381T3/es not_active Expired - Lifetime
- 1991-04-16 DK DK91200897T patent/DK0453042T3/da active
- 1991-04-16 AT AT91200897T patent/ATE186301T1/de not_active IP Right Cessation
- 1991-04-17 IL IL9789291A patent/IL97892A/en not_active IP Right Cessation
- 1991-04-17 KR KR1019910006108A patent/KR100190297B1/ko not_active IP Right Cessation
- 1991-04-18 NO NO911525A patent/NO176840C/no not_active IP Right Cessation
- 1991-04-18 FI FI911885A patent/FI96206C/fi active
- 1991-04-18 PL PL91312561A patent/PL169744B1/pl unknown
- 1991-04-18 ZA ZA912913A patent/ZA912913B/xx unknown
- 1991-04-18 SK SK1099-91A patent/SK279005B6/sk not_active IP Right Cessation
- 1991-04-18 PT PT97395A patent/PT97395B/pt not_active IP Right Cessation
- 1991-04-18 CZ CS911099A patent/CZ281135B6/cs not_active IP Right Cessation
- 1991-04-18 BG BG94282A patent/BG60394B1/bg unknown
- 1991-04-18 RU SU914895183A patent/RU2037495C1/ru active
- 1991-04-18 PL PL91289935A patent/PL169740B1/pl unknown
- 1991-04-18 IE IE130191A patent/IE911301A1/en not_active IP Right Cessation
- 1991-04-19 CN CN91102516A patent/CN1027506C/zh not_active Expired - Lifetime
- 1991-04-19 HU HU911301A patent/HUT57763A/hu unknown
-
1999
- 1999-12-14 GR GR990403201T patent/GR3032122T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0453042T3 (da) | Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner | |
| DK0482208T3 (da) | Pyridazinonderivat | |
| ATE51621T1 (de) | Bicyclische kondensierte n-(4-piperidinyl)-2imidazolamin-derivate. | |
| FI900085A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| ATE78470T1 (de) | Imidazolin-derivate und verfahren zu deren herstellung. | |
| DE3874013T2 (de) | N-(4-piperidinyl)-bizyklisch kondensierte 2-imidazolamin-derivate. | |
| NO176608C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidinylindazol-derivater | |
| DE3884878T2 (de) | Uricosuretische Zusammensetzung. |